Tetiana Hedz Appointed Head of Pharmaceutical Trade Regulation Department at Ukraine’s State Service on Medicines

Image: Illustrative / Flow AI

Kyiv, Ukraine — July 2026 — Tetiana Hedz has been appointed head of the Department for Wholesale and Retail Trade in Medicinal Products at Ukraine’s State Service on Medicines and Drugs Control, strengthening the agency’s leadership responsible for monitoring pharmaceutical distribution.

The appointment comes as Ukraine continues efforts to improve oversight of the pharmaceutical market, ensure the availability of medicines, and maintain compliance with regulatory standards during wartime conditions.

Focus on Pharmaceutical Market Oversight

The Department for Wholesale and Retail Trade in Medicinal Products plays a key role in regulating the circulation of medicines in Ukraine, including issues related to pharmaceutical supply chains, licensing requirements, and compliance among pharmacies and distributors.

The department’s work is aimed at ensuring that medicines reach patients safely and that businesses operating in the pharmaceutical sector follow national regulations.

Experts note that effective oversight of medicine distribution remains particularly important during periods of instability, when supply chains can face additional challenges.

Strengthening Control Over Medicine Availability

Ukraine’s pharmaceutical sector has continued operating under significant pressure since the beginning of Russia’s full-scale invasion. Damage to infrastructure, logistical disruptions, and increased demand for certain categories of medicines have created additional challenges for regulators and healthcare providers.

Authorities have emphasized the importance of maintaining stable access to essential medicines while improving transparency and accountability across the market.

The State Service on Medicines and Drugs Control remains one of the key institutions responsible for supervising pharmaceutical activities in the country.

Leadership Changes in the Healthcare Sector

The appointment of new leadership within regulatory institutions is part of ongoing efforts to improve management and strengthen public administration in Ukraine’s healthcare system.

Specialists say that experienced leadership in pharmaceutical regulation is essential for implementing modern standards, improving cooperation with market participants, and protecting patients’ interests.

Future Priorities for Pharmaceutical Regulation

Among the major challenges facing the sector are maintaining medicine quality, preventing illegal circulation of pharmaceutical products, and adapting regulatory processes to European standards.

As Ukraine continues its integration with European institutions, healthcare regulators are expected to play an important role in aligning national pharmaceutical policies with international practices.

The appointment of Tetiana Hedz marks another step in the development of Ukraine’s pharmaceutical governance system.